Report from the Extraordinary General Meeting of Gambro AB

Report from the Extraordinary General Meeting of Gambro AB Gambro AB's Extraordinary General Meeting resolved today, in accordance with the Board of Directors' proposal, to issue call options giving Gambro share- holders the right to acquire the greater part of the Group's shareholding in ABB AB. The decision means that Gambro shareholders will be entitled to acquire one Series A share in ABB at a price of SEK 55 per ABB share for each three Series A or B shares held in Gambro. The following detailed decisions were made regarding the transaction: The par value of the share will be changed from SEK 2 to SEK 1. The shares will be split 2:1 . The share capital will be reduced by SEK 342 M through redemption of shares accompanied with repayment to shareholders. A new share issue of 2.8 million shares with a value corresponding to SEK 342 M will be implemented. The par value of the share will be changed from SEK 1 back to SEK 2. A bonus issue will be implemented by increasing the par value of the share to SEK 2, which will have the effect of increasing the share capital by SEK 345. The transaction is described in detail in the previously published prospectus entitled "Information on offer to acquire ABB shares at a substantial discount." For further information: Bengt Modéer, Senior Vice President, Corporate Communications, +46-8-613 65 00, +46-70-513 65 33 Gambro is an international medical-technology group with revenues of approximately SEK 18 billion and about 17,000 employees in some 40 countries.